|
|
|
Insider
Information: |
Kathiresan Sekar |
Relationship: |
Chief Executive Office... |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
317,839 |
|
Indirect Shares
|
321,994 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
639,833 |
|
|
Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
|
|
Stock
price went down : |
|
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Verve Therapeutics, Inc. |
VERV |
Chief Executive Office... |
2022-10-03 |
317,839 |
2022-10-03 |
321,994 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
20 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VERV |
Verve Therapeutics, Inc. |
Chief Executive Officer |
|
2022-07-07 |
4 |
GA |
$0.00 |
$0 |
I/I |
160,000 |
240,997 |
0 |
- |
|
VERV |
Verve Therapeutics, Inc. |
Chief Executive Officer |
|
2022-07-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
160,000 |
317,839 |
0 |
- |
|
VERV |
Verve Therapeutics, Inc. |
Chief Executive Officer |
|
2022-01-04 |
4 |
OE |
$1.39 |
$2,599 |
D/D |
1,870 |
408,406 |
0 |
- |
|
VERV |
Verve Therapeutics, Inc. |
Chief Executive Officer |
|
2021-12-28 |
4 |
OE |
$1.39 |
$9,303 |
D/D |
6,693 |
413,229 |
0 |
- |
|
VERV |
Verve Therapeutics, Inc. |
Chief Executive Officer |
|
2021-06-21 |
4 |
B |
$19.00 |
$47,500 |
D/D |
2,500 |
406,536 |
2.81 |
- |
|
VERV |
Verve Therapeutics, Inc. |
Chief Executive Officer |
|
2021-12-27 |
4 |
OE |
$1.39 |
$58,380 |
D/D |
42,000 |
448,536 |
0 |
- |
|
VERV |
Verve Therapeutics, Inc. |
Chief Executive Officer |
|
2022-07-19 |
4 |
OE |
$1.39 |
$69,500 |
D/D |
50,000 |
367,839 |
0 |
- |
|
VERV |
Verve Therapeutics, Inc. |
Chief Executive Officer |
|
2022-08-10 |
4 |
OE |
$1.39 |
$69,500 |
D/D |
50,000 |
367,839 |
0 |
- |
|
VERV |
Verve Therapeutics, Inc. |
Chief Executive Officer |
|
2022-10-03 |
4 |
OE |
$1.39 |
$69,500 |
D/D |
50,000 |
367,839 |
0 |
- |
|
VERV |
Verve Therapeutics, Inc. |
Chief Executive Officer |
|
2022-01-04 |
4 |
AS |
$39.90 |
$74,613 |
D/D |
(1,870) |
406,536 |
0 |
- |
|
VERV |
Verve Therapeutics, Inc. |
Chief Executive Officer |
|
2021-12-22 |
4 |
OE |
$1.39 |
$79,230 |
D/D |
57,000 |
463,536 |
0 |
- |
|
VERV |
Verve Therapeutics, Inc. |
Chief Executive Officer |
|
2021-12-23 |
4 |
OE |
$1.39 |
$79,230 |
D/D |
57,000 |
463,536 |
0 |
- |
|
VERV |
Verve Therapeutics, Inc. |
Chief Executive Officer |
|
2022-03-18 |
4 |
OE |
$2.87 |
$199,964 |
D/D |
69,674 |
477,525 |
0 |
- |
|
VERV |
Verve Therapeutics, Inc. |
Chief Executive Officer |
|
2021-12-28 |
4 |
AS |
$39.90 |
$267,051 |
D/D |
(6,693) |
406,536 |
0 |
- |
|
VERV |
Verve Therapeutics, Inc. |
Chief Executive Officer |
|
2022-07-19 |
4 |
AS |
$29.90 |
$1,495,000 |
D/D |
(50,000) |
317,839 |
0 |
- |
|
VERV |
Verve Therapeutics, Inc. |
Chief Executive Officer |
|
2022-08-10 |
4 |
AS |
$29.90 |
$1,495,000 |
D/D |
(50,000) |
317,839 |
0 |
- |
|
VERV |
Verve Therapeutics, Inc. |
Chief Executive Officer |
|
2022-10-03 |
4 |
AS |
$33.02 |
$1,682,622 |
D/D |
(50,000) |
317,839 |
0 |
- |
|
VERV |
Verve Therapeutics, Inc. |
Chief Executive Officer |
|
2021-12-27 |
4 |
AS |
$40.02 |
$1,688,484 |
D/D |
(42,000) |
406,536 |
0 |
- |
|
VERV |
Verve Therapeutics, Inc. |
Chief Executive Officer |
|
2021-12-22 |
4 |
AS |
$37.38 |
$2,206,304 |
D/D |
(57,000) |
406,536 |
0 |
- |
|
VERV |
Verve Therapeutics, Inc. |
Chief Executive Officer |
|
2021-12-23 |
4 |
AS |
$39.90 |
$2,274,300 |
D/D |
(57,000) |
406,536 |
0 |
- |
|
20 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|